Cost Effectiveness of Interferon-Gamma Release Assay versus Chest X-Ray for Tuberculosis Screening of BCG-Vaccinated Elderly Populations (Q51151355)

31 March 2018

title

Cost Effectiveness of Interferon-Gamma Release Assay versus Chest X-Ray for Tuberculosis Screening of BCG-Vaccinated Elderly Populations (English)

1 reference

2 July 2024

1 reference

1

Akiko Kowada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20799765

2 July 2024

author name string

Osamu Takahashi

3

1 reference

31 March 2018

Takuro Shimbo

4

1 reference

31 March 2018

Tsuguya Fukui

5

1 reference

31 March 2018

Gautam A. Deshpande

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20799765

2 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20799765

2 July 2024

publication date

1 August 2010

1 reference

31 March 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF03256378.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF03256378/fulltext.html

2 July 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF03256378

2 July 2024

1 reference

Molecular Diagnosis and Therapy

2 July 2024

published in

1 reference

31 March 2018

volume

14

1 reference

31 March 2018

issue

4

1 reference

31 March 2018

page(s)

229-236

1 reference

31 March 2018

Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Benefit-risk considerations in preventive treatment for tuberculosis in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Use of Isoniazid for Latent Tuberculosis Infection in a Public Health Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Cost-effectiveness of tuberculosis control strategies among immigrants and refugees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Cost-effectiveness of isoniazid chemoprevention in close contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35 years of age: a risk-benefit and cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Indeterminate test results of T-SPOT.TB performed under routine field conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

The role of chest CT scanning in TB outbreak investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Priorities for the Treatment of Latent Tuberculosis Infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256378

Combined use of QuantiFERON-TB Gold assay and chest computed tomography in a tuberculosis outbreak

21 January 2018

1 reference

12 December 2020

Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis.

1 reference

12 December 2020

Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis

1 reference

12 December 2020

Cost effectiveness of interferon-gamma release assay for tuberculosis contact screening in Japan

1 reference

12 December 2020

[Cost effectiveness analysis of isoniazid preventive therapy to the contacts of tuberculosis patients under Japanese settings]

1 reference

12 December 2020

Drug-resistant Mycobacterium tuberculosis in Japan: a nationwide survey, 2002.

1 reference

12 December 2020

Relapse rate of tuberculosis treated with standard regimen of chemotherapy

1 reference

12 December 2020

Bulletin of the World Health Organization

13

60

555

International Union Against Tuberculosis Committee on Prophylaxis.

publication date

1982

1 reference

2 July 2024

Identifiers

DOI

10.1007/BF03256378

1 reference

31 March 2018

1 reference

31 March 2018